The Angelman Syndrome Protein Ube3a Is Required for Polarized Dendrite Morphogenesis in Pyramidal Neurons

被引:77
|
作者
Miao, Sheng [1 ,2 ]
Chen, Renchao [1 ,2 ]
Ye, Jiahao [1 ,2 ]
Tan, Guo-He [1 ,2 ]
Li, Shuai [1 ,2 ]
Zhang, Jing [1 ,2 ]
Jiang, Yong-hui [3 ]
Xiong, Zhi-Qi [1 ,2 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China
[3] Duke Univ, Div Med Genet, Dept Pediat, Sch Med, Durham, NC 27710 USA
基金
中国国家自然科学基金;
关键词
UBIQUITIN LIGASE; E6-ASSOCIATED PROTEIN; CEREBRAL-CORTEX; GENE-TRANSFER; MIGRATION; SYNAPSE; ELECTROPORATION; DEGRADATION; ORIENTATION; NEOCORTEX;
D O I
10.1523/JNEUROSCI.2509-12.2013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pyramidal neurons have a highly polarized dendritic morphology, characterized by one long apical dendrite and multiple short basal dendrites. They function as the primary excitatory cells of the mammalian prefrontal cortex and the corticospinal tract. However, the molecular mechanisms underlying the development of polarized dendrite morphology in pyramidal neurons remain poorly understood. Here, we report that the Angelman syndrome (AS) protein ubiquitin-protein ligase E3A (Ube3a) plays an important role in specifying the polarization of pyramidal neuron dendritic arbors in mice. shRNA-mediated downregulation of Ube3a selectively inhibited apical dendrite outgrowth and resulted in impaired dendrite polarity, which could be rescued by coexpressing mouse Ube3a isoform 2, but not isoform 1 or 3. Ube3a knockdown also disrupted the polarized distribution of the Golgi apparatus, a well established cellular mechanism for asymmetric dendritic growth in pyramidal neurons. Furthermore, downregulation of Ube3a completely blocked Reelin-induced rapid deployment of Golgi into dendrite. Consistently, we also observed selective inhibition of apical dendrite outgrowth in pyramidal neurons in a mouse model of AS. Overall, these results show that Ube3a is required for the specification of the apical dendrites and dendrite polarization in pyramidal neurons, and suggest a novel pathological mechanism for AS.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 49 条
  • [1] Mutation Update for UBE3A Variants in Angelman Syndrome
    Sadikovic, Bekim
    Fernandes, Priscilla
    Zhang, Victor Wei
    Ward, Patricia A.
    Miloslavskaya, Irene
    Rhead, William
    Rosenbaum, Richard
    Gin, Robert
    Roa, Benjamin
    Fang, Ping
    HUMAN MUTATION, 2014, 35 (12) : 1407 - 1417
  • [2] Ube3a unsilencer for the potential treatment of Angelman syndrome
    Vihma, Hanna
    Li, Kelin
    Welton-Arndt, Anna
    Smith, Audrey L.
    Bettadapur, Kiran R.
    Gilmore, Rachel B.
    Gao, Eric
    Cotney, Justin L.
    Huang, Hsueh-Cheng
    Collins, Jon L.
    Chamberlain, Stormy J.
    Lee, Hyeong-Min
    Aube, Jeffrey
    Philpot, Benjamin D.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [3] The Angelman Syndrome Protein Ube3a/E6AP Is Required for Golgi Acidification and Surface Protein Sialylation
    Condon, Kathryn H.
    Ho, Jianghai
    Robinson, Camenzind G.
    Hanus, Cyril
    Ehlers, Michael D.
    JOURNAL OF NEUROSCIENCE, 2013, 33 (09) : 3799 - 3814
  • [4] From UBE3A to Angelman syndrome: a substrate perspective
    Sell, Gabrielle L.
    Margolis, Seth S.
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [5] Ube3a Imprinting Impairs Circadian Robustness in Angelman Syndrome Models
    Shi, Shu-qun
    Bichell, Terry Jo
    Ihrie, Rebecca A.
    Johnson, Carl Hirschie
    CURRENT BIOLOGY, 2015, 25 (05) : 537 - 545
  • [6] Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome
    Gustin, Richard M.
    Bichell, Terry Jo
    Bubser, Michael
    Daily, Jennifer
    Filonova, Irina
    Mrelashvili, Davit
    Deutch, Ariel Y.
    Colbran, Roger J.
    Weeber, Edwin J.
    Haas, Kevin F.
    NEUROBIOLOGY OF DISEASE, 2010, 39 (03) : 283 - 291
  • [7] Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome
    Su, Hailing
    Fan, Weiwei
    Coskun, Pinar E.
    Vesa, Jouni
    Gold, June-Anne
    Jiang, Yong-Hui
    Potluri, Prasanth
    Procaccio, Vincent
    Acab, Allan
    Weiss, John H.
    Wallace, Douglas C.
    Kimonis, Virginia E.
    NEUROSCIENCE LETTERS, 2011, 487 (02) : 129 - 133
  • [8] Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
    Bossuyt, Stijn N., V
    Punt, A. Mattijs
    de Graaf, Ilona J.
    van den Burg, Janny
    Williams, Mark G.
    Heussler, Helen
    Elgersma, Ype
    Distel, Ben
    HUMAN MOLECULAR GENETICS, 2021, 30 (06) : 430 - 442
  • [9] Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome
    Krzeski, Joseph C.
    Judson, Matthew C.
    Philpot, Benjamin D.
    CURRENT OPINION IN NEUROBIOLOGY, 2024, 88
  • [10] Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a
    Sato, Masaaki
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2017, 11